DK1200092T3 - Beta-carbolin-lægemiddelprodukter - Google Patents

Beta-carbolin-lægemiddelprodukter

Info

Publication number: DK1200092T3
Authority: DK; Denmark
Prior art keywords: carboline; beta; drug products; drug; products
Prior art date: 1999-08-03

Application number

DK00952371T

Other languages

English (en)

Inventor

Neil R Anderson

Kerry J Hartauer

Martha A Kral

Gregory A Stephenson

Original Assignee

Lilly Icos Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-03

Filing date

2000-08-01

Publication date

2004-08-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22520112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1200092(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-08-01 Application filed by Lilly Icos Llc filed Critical Lilly Icos Llc

2004-08-16 Application granted granted Critical

2004-08-16 Publication of DK1200092T3 publication Critical patent/DK1200092T3/da

Links

AIFRHYZBTHREPW-UHFFFAOYSA-N β-carboline Chemical compound N1=CC=C2C3=CC=CC=C3NC2=C1 AIFRHYZBTHREPW-UHFFFAOYSA-N 0.000 title 2
229940126534 drug product Drugs 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Physical Or Chemical Processes And Apparatus (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK00952371T 1999-08-03 2000-08-01 Beta-carbolin-lægemiddelprodukter DK1200092T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US14704899P	1999-08-03	1999-08-03
PCT/US2000/020981 WO2001008688A2 (en)	1999-08-03	2000-08-01	Beta-carboline drug products

Publications (1)

Publication Number	Publication Date
DK1200092T3 true DK1200092T3 (da)	2004-08-16

Family

ID=22520112

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00952371T DK1200092T3 (da)	1999-08-03	2000-08-01	Beta-carbolin-lægemiddelprodukter

Country Status (33)

Country	Link
EP (1)	EP1200092B1 (da)
JP (1)	JP4456788B2 (da)
KR (1)	KR20020063842A (da)
CN (2)	CN1377270A (da)
AR (1)	AR033953A1 (da)
AT (1)	ATE264680T1 (da)
AU (1)	AU773666B2 (da)
BR (1)	BR0012901A (da)
CA (1)	CA2380087C (da)
CO (1)	CO5200849A1 (da)
CZ (1)	CZ300151B6 (da)
DE (1)	DE60010089T2 (da)
DK (1)	DK1200092T3 (da)
DZ (1)	DZ3180A1 (da)
EA (1)	EA004302B9 (da)
ES (1)	ES2220506T3 (da)
HK (1)	HK1044278B (da)
HR (1)	HRP20020091B1 (da)
HU (1)	HU229443B1 (da)
IL (1)	IL147642A0 (da)
MX (1)	MXPA02001197A (da)
MY (1)	MY125428A (da)
NO (1)	NO321602B1 (da)
NZ (1)	NZ516613A (da)
PE (1)	PE20010480A1 (da)
PL (1)	PL199469B1 (da)
PT (1)	PT1200092E (da)
SK (1)	SK286365B6 (da)
SV (1)	SV2002000137A (da)
TW (1)	TWI235658B (da)
UA (1)	UA71629C2 (da)
WO (1)	WO2001008688A2 (da)
ZA (1)	ZA200200825B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ516616A (en) *	1999-08-03	2003-07-25	Lilly Icos Llc	Beta-carboline pharmaceutical compositions
WO2006049986A1 (en) *	2004-10-28	2006-05-11	Dr. Reddy's Laboratories Ltd.	Polymorphic forms of tadalafil
DE602006004694D1 (de)	2006-01-05	2009-02-26	Teva Pharma	Feuchtgranulierungsmethode zur Herstellung pharmazeutischer Aripiprazolzusammensetzungen
DE102007028869A1 (de) *	2007-06-22	2008-12-24	Ratiopharm Gmbh	Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil
MD4009C2 (ro) *	2008-07-15	2010-08-31	Институт Химии Академии Наук Молдовы	Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
DE102009033396A1 (de)	2009-07-16	2011-01-20	Ratiopharm Gmbh	Wässrige Lösung und gelatinierte Zusammensetzung umfassend einen Phosphodiesterase-5-Inhibitor sowie diesbezügliche Verfahren und Verwendung
DE102009035211A1 (de)	2009-07-29	2011-02-17	Ratiopharm Gmbh	Copräzipitate umfassend einen Phosphodiesterase-5-Inhibitor (PDE-5-Inhibitor) und einen pharmazeutisch verträglichen Trägerstoff, ihre Herstellung und Verwendung
WO2012085927A2 (en) *	2010-12-02	2012-06-28	Mylan Laboratories, Limited	Tadalafil compositions
WO2012095151A1 (en)	2010-12-23	2012-07-19	Zaklady Farmaceutyczne Polpharma Sa	Solid pharmaceutical dosage forms comprising tadalafil and methods of preparation thereof
WO2012107092A1 (en)	2011-02-10	2012-08-16	Synthon Bv	Pharmaceutical composition comprising tadalafil and a cyclodextrin
WO2012107541A1 (en)	2011-02-10	2012-08-16	Synthon Bv	Pharmaceutical composition comprising tadalafil and a cyclodextrin
WO2012107090A1 (en)	2011-02-10	2012-08-16	Synthon Bv	Granulated composition comprising tadalafil and a disintegrant
JP5930686B2 (ja) *	2011-12-07	2016-06-08	株式会社トクヤマ	溶解性および安定性の向上した難溶性医薬品原体及びその製造方法
KR102268696B1 (ko)	2012-03-15	2021-06-23	메르크 파텐트 게엠베하	전자 소자
WO2014003678A1 (en) *	2012-06-28	2014-01-03	Xspray Microparticles Ab	Pharmaceutical compositions comprising ambrisentan and solid dispersion particles containing tadalafil
WO2014003677A1 (en) *	2012-06-28	2014-01-03	Xspray Microparticles Ab	Pharmaceutical compositions comprising solid dispersion particles containing tadalafil
CN105310984A (zh) *	2014-06-10	2016-02-10	合肥贝霓医药科技有限公司	一种pde5抑制剂的超微粉体及其制备方法
JP6445559B2 (ja) *	2014-06-24	2018-12-26	ウーシンラボタチカンパニー, リミテッドWooshin Labottach Co., Ltd.	タダラフィルを含む口腔内崩壊フィルム製剤およびその製造方法
EA035390B1 (ru)	2014-07-23	2020-06-05	КРКА, д.д., НОВО МЕСТО	Совместный осадок тадалафила с фармацевтически приемлемыми эксципиентами, содержащая его фармацевтическая композиция и способ их получения
JP2016106139A (ja) *	2016-03-07	2016-06-16	株式会社トクヤマ	溶解性および安定性の向上した難溶性医薬品原体及びその製造方法
AU2018397436A1 (en)	2017-12-26	2020-08-13	Ftf Pharma Private Limited	Liquid oral formulations for PDE V inhibitors
LT3510997T (lt)	2018-01-10	2021-01-11	Gap S.A.	Minkšta želatinos kapsulė, apimanti tadalafilio suspensiją
CN110638770B (zh) *	2019-10-25	2022-04-05	株洲千金药业股份有限公司	他达拉非片剂的制备方法及以该方法制得的片剂
EP4531815A1 (en) *	2022-05-27	2025-04-09	Rontis Hellas S.A.	Improved pharmaceutical composition containing tadalafil and nanomilling process for the preparation thereof
CN119112817A (zh) *	2024-08-20	2024-12-13	武汉九珑人福药业有限责任公司	一种他达拉非片及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5618845A (en) *	1994-10-06	1997-04-08	Cephalon, Inc.	Acetamide derivative having defined particle size
GB9511220D0 (en) *	1995-06-02	1995-07-26	Glaxo Group Ltd	Solid dispersions

2000
- 2000-01-08 UA UA2002010773A patent/UA71629C2/uk unknown
- 2000-08-01 IL IL14764200A patent/IL147642A0/xx active IP Right Grant
- 2000-08-01 KR KR1020027001407A patent/KR20020063842A/ko not_active Ceased
- 2000-08-01 PL PL353268A patent/PL199469B1/pl unknown
- 2000-08-01 AU AU65084/00A patent/AU773666B2/en not_active Expired
- 2000-08-01 CA CA002380087A patent/CA2380087C/en not_active Expired - Lifetime
- 2000-08-01 SK SK172-2002A patent/SK286365B6/sk not_active IP Right Cessation
- 2000-08-01 NZ NZ516613A patent/NZ516613A/en not_active IP Right Cessation
- 2000-08-01 MX MXPA02001197A patent/MXPA02001197A/es active IP Right Grant
- 2000-08-01 DK DK00952371T patent/DK1200092T3/da active
- 2000-08-01 EP EP00952371A patent/EP1200092B1/en not_active Expired - Lifetime
- 2000-08-01 DE DE60010089T patent/DE60010089T2/de not_active Expired - Lifetime
- 2000-08-01 HR HR20020091A patent/HRP20020091B1/xx not_active IP Right Cessation
- 2000-08-01 BR BR0012901-1A patent/BR0012901A/pt not_active Application Discontinuation
- 2000-08-01 HK HK02104540.5A patent/HK1044278B/en not_active IP Right Cessation
- 2000-08-01 ES ES00952371T patent/ES2220506T3/es not_active Expired - Lifetime
- 2000-08-01 HU HU0202781A patent/HU229443B1/hu unknown
- 2000-08-01 CN CN00813777A patent/CN1377270A/zh active Pending
- 2000-08-01 JP JP2001513418A patent/JP4456788B2/ja not_active Expired - Lifetime
- 2000-08-01 CN CNA2007101408018A patent/CN101134019A/zh active Pending
- 2000-08-01 WO PCT/US2000/020981 patent/WO2001008688A2/en not_active Ceased
- 2000-08-01 CZ CZ20020387A patent/CZ300151B6/cs not_active IP Right Cessation
- 2000-08-01 PT PT00952371T patent/PT1200092E/pt unknown
- 2000-08-01 DZ DZ003180A patent/DZ3180A1/xx active
- 2000-08-01 EA EA200200119A patent/EA004302B9/ru not_active IP Right Cessation
- 2000-08-01 AT AT00952371T patent/ATE264680T1/de active
- 2000-08-02 CO CO00058156A patent/CO5200849A1/es not_active Application Discontinuation
- 2000-08-02 MY MYPI20003524 patent/MY125428A/en unknown
- 2000-08-03 PE PE2000000773A patent/PE20010480A1/es not_active IP Right Cessation
- 2000-08-03 AR ARP000104015A patent/AR033953A1/es not_active Application Discontinuation
- 2000-08-03 TW TW089115586A patent/TWI235658B/zh not_active IP Right Cessation
- 2000-08-07 SV SV2000000137A patent/SV2002000137A/es unknown
2002
- 2002-01-30 ZA ZA200200825A patent/ZA200200825B/en unknown
- 2002-02-01 NO NO20020531A patent/NO321602B1/no unknown

Also Published As

Publication number	Publication date
EA200200119A1 (ru)	2002-06-27
EA004302B1 (ru)	2004-02-26
NO20020531L (no)	2002-04-03
CZ2002387A3 (cs)	2002-10-16
DE60010089D1 (de)	2004-05-27
KR20020063842A (ko)	2002-08-05
MXPA02001197A (es)	2003-02-12
HK1044278B (en)	2004-10-08
PL353268A1 (en)	2003-11-03
HK1044278A1 (en)	2002-10-18
WO2001008688A2 (en)	2001-02-08
CA2380087A1 (en)	2001-02-08
CA2380087C (en)	2007-05-01
JP2003505510A (ja)	2003-02-12
BR0012901A (pt)	2002-04-16
ES2220506T3 (es)	2004-12-16
HU229443B1 (en)	2013-12-30
EA004302B9 (ru)	2019-01-31
DE60010089T2 (de)	2004-10-14
SK1722002A3 (en)	2002-05-09
AU773666B2 (en)	2004-06-03
MY125428A (en)	2006-07-31
NZ516613A (en)	2003-08-29
PT1200092E (pt)	2004-07-30
AR033953A1 (es)	2004-01-21
SK286365B6 (sk)	2008-08-05
ATE264680T1 (de)	2004-05-15
NO321602B1 (no)	2006-06-12
PE20010480A1 (es)	2001-05-26
DZ3180A1 (fr)	2001-02-08
IL147642A0 (en)	2002-08-14
HUP0202781A2 (hu)	2002-12-28
HUP0202781A3 (en)	2003-10-28
HRP20020091A2 (en)	2004-02-29
NO20020531D0 (no)	2002-02-01
UA71629C2 (en)	2004-12-15
SV2002000137A (es)	2002-06-07
CZ300151B6 (cs)	2009-02-25
JP4456788B2 (ja)	2010-04-28
PL199469B1 (pl)	2008-09-30
EP1200092A2 (en)	2002-05-02
WO2001008688A3 (en)	2001-08-16
EP1200092B1 (en)	2004-04-21
ZA200200825B (en)	2003-04-30
CN101134019A (zh)	2008-03-05
AU6508400A (en)	2001-02-19
HRP20020091B1 (en)	2006-02-28
CO5200849A1 (es)	2002-09-27
CN1377270A (zh)	2002-10-30
TWI235658B (en)	2005-07-11

Publication	Publication Date	Title
DE60010089D1 (de)	2004-05-27	Beta-carbolin arzneistoffprodukte
NO20022970D0 (no)	2002-06-20	Hydrogel-drevet medikamentdoseringsform
DE60016271D1 (de)	2004-12-30	Medikamentenzuführvorrichtung
NO20015175L (no)	2001-10-23	Farmasöytisk sammensetning
ATE352339T1 (de)	2007-02-15	Medikamentspender
NO20020464L (no)	2002-03-20	Flerkomponents farmasöytisk doseringsform
DK1128831T3 (da)	2005-01-17	Farmaceutisk moxifloxacinpræparat
NO20020086L (no)	2002-03-05	Smaksmaskerte farmasöytiske flytende formuleringer
NO20015670L (no)	2001-11-20	Forbedrede farmasöytiske formuleringer
FI20000976A7 (fi)	2000-10-30	Tuotteita
PT1173434E (pt)	2003-12-31	Novo produto farmaceutico
NO20022606D0 (no)	2002-05-31	Farmasöytiske kombinasjoner
DK1275397T3 (da)	2014-09-22	Lægemiddel til lokal anvendelse
NO20014926L (no)	2001-12-13	Farmasöytiske forbindelser
FR2802423B1 (fr)	2005-03-25	Compositions pharmaceutiques
AR025867A1 (es)	2002-12-18	Formulacion portasdora farmaceutica
FI4488U1 (fi)	2000-07-20	Farmaseuttinen koostumus
NO20016430D0 (no)	2001-12-28	Farmasöytisk kompleks
NO20021036L (no)	2002-04-26	Farmasöytisk preparat
SI1200092T1 (en)	2004-12-31	Beta-carboline drug products
ATA173599A (de)	2001-04-15	Pharmazeutisches produkt
FIU990361U0 (fi)	1999-08-27	Hammaslankatuote
FIU990118U0 (fi)	1999-03-10	Hammaslankatuote
DK1183061T3 (da)	2005-08-01	Lægemiddelafgivelsessystem
UA3648S (uk)	2000-09-15	Пляшка для лікеро-горілчаних виробів